3-Quinolinecarboxamide, N-cyclooctyl-1,2-dihydro-4-hydroxy-2-oxo-(300836-55-9)
- Name: 3-Quinolinecarboxamide, N-cyclooctyl-1,2-dihydro-4-hydroxy-2-oxo-
- Synonyms:
- Molecular Formula:C18H22N2O3
- Molecular Weight:0.00000
- CAS Registry Number:300836-55-9
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.300836-55-9 3-Quinolinecarboxamide, N-cyclooctyl-1,2-dihydro-4-hydroxy-2-oxo-
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]

Other Product
- 300831-18-9/4-Quinolinol, 7-methoxy-2-(5-oxazolyl)-
- 300831-22-5/2-Oxazolidinone, 3-(1-oxo-8-nonenyl)-4-(phenylmethyl)-, (4S)-
- 300831-23-6/2-Oxazolidinone, 3-[(2S)-2-azido-1-oxo-8-nonenyl]-4-(phenylmethyl)-, (4S)-
- 300831-24-7/Carbamic acid, [(1S)-1-[[(4S)-2-oxo-4-(phenylmethyl)-3-oxazolidinyl]carbonyl]-7-octenyl] -, 1,1-dimethylethyl ester
- 300831-26-9/Heptanedioic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-5-oxo-, 1-methyl 7-(2-propenyl) ester, (2S)-
- 300831-27-0/8-Nonenoic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-5-oxo-, methyl ester, (2S)-
- 300831-28-1/8-Decenoic acid, 2-(acetylamino)-5,9-dimethyl-, ethyl ester, (2S,5R)-
- 300831-29-2/Decanoic acid, 2-(acetylamino)-8,9-dihydroxy-5,9-dimethyl-, ethyl ester, (2S,5S)-
- 300831-30-5/Octanoic acid, 2-(acetylamino)-5-methyl-8-oxo-, ethyl ester, (2S,5S)-
- 300831-31-6/8-Nonenoic acid, 2-(acetylamino)-5-methyl-, ethyl ester, (2S,5R)-
- 300831-35-0/8-Nonenoic acid, 2-(acetylamino)-5-methyl-, (2S,5R)-
- 300831-37-2/L-Threonine, N-[(1,1-dimethylethoxy)carbonyl]-O-2-propenyl-
- 300831-38-3/Butanoic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-3-(2-propenylthio)-, methyl ester, (2R,3S)-
- 300831-52-1/Cyclopropanecarboxylic acid, 1-[[[(2S,4R)-1-[(2S)-2-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxo-4-[[( phenylmethoxy)carbonyl]amino]butyl]-4-[(7-methoxy-2-phenyl-4-quinolin yl)oxy]-2-pyrrolidinyl]carbonyl]amino]-2-(4-hydroxybutyl)-, methyl ester, (1R,2R)-
- 300831-53-2/Cyclopropanecarboxylic acid, 1-[[[(2S,4R)-1-[(2S)-2-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxo-4-[[( phenylmethoxy)carbonyl]amino]butyl]-4-[(7-methoxy-2-phenyl-4-quinolin yl)oxy]-2-pyrrolidinyl]carbonyl]amino]-2-(4-oxobutyl)-, methyl ester, (1R,2R)-
- 300831-59-8/Cyclopropanecarboxylic acid, 1-[[[(2S,4R)-1-[(2S)-2-[[(1,1-dimethylethoxy)carbonyl]amino]-1,5-dioxo- 8-nonenyl]-4-[(7-methoxy-2-phenyl-4-quinolinyl)oxy]-2-pyrrolidinyl]carbon yl]amino]-2-ethenyl-, methyl ester, (1R,2S)-
- 300831-67-8/Cyclopropanecarboxylic acid, 1-[[[(2S,4S)-1-[(2S,5R)-2-[[(1,1-dimethylethoxy)carbonyl]amino]-5-meth yl-1-oxo-8-nonenyl]-4-hydroxy-2-pyrrolidinyl]carbonyl]amino]-2-ethenyl-, methyl ester, (1R,2S)-
- 300834-24-6/3-Quinolinecarboxamide, N-(2-cyanophenyl)-1-ethyl-1,2-dihydro-4-hydroxy-2-oxo-
- 300835-44-3/5H-Indeno[1,2-b]pyridine, 7-methyl-5-[(4-nitrophenyl)methylene]-
- 300836-55-9/3-Quinolinecarboxamide, N-cyclooctyl-1,2-dihydro-4-hydroxy-2-oxo-
- 300838-06-6/2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1,3-benzodioxol-5-ylmethyl)-1,3-dimethyl-
- 300838-11-3/2-Furancarboxamide, N,N'-[1,3-phenylenebis(oxy-4,1-phenylene)]bis-
- 300838-36-2/Imidazo[4,5-g]indolizin-6-ium, 9-(1,3-benzodioxol-5-ylmethylene)-3,9-dihydro-2,3,7-trimethyl-8-phenyl-
- 300838-47-5/2-Butenoic acid, 2-hydroxy-4-(3-nitrophenyl)-4-oxo-
- 300840-04-4/Bicyclo[7.2.0]undec-5-en-4-ol, 6,10,10-trimethyl-2-methylene-, (1S,5Z,9R)-
- 30084-15-2/1,3,5-Triazine-2,4,6-triamine, N-(2-phenylethyl)-
- 300843-20-3/Methanone, [4-[(4-chlorophenyl)amino]-1-phthalazinyl]-4-pyridinyl-
- 300843-21-4/1-Phthalazinemethanol, 4-[(4-chlorophenyl)amino]-a-(1-oxido-4-pyridinyl)-
- 300844-09-1/Acetic acid, [[4-(4-chlorophenyl)-3-cyano-6-(2-thienyl)-2-pyridinyl]thio]-, ethyl ester
- 300848-83-3/Benzene, 1,4-bis[(1E)-2-[4-[2-(2-butoxyethoxy)ethoxy]-3,5-dimethoxyphenyl]ethen yl]-